ARCHIVES

M.D. Anderson Sells Itself As Research Base For CCOPs

This article is from The Cancer Letter archive.

Vol. 12 No. 32 | August 8, 1986

Download PDF Visit The Full Archive

Related Articles

Low-Dose IFN Not Effective Against Melanoma, Study Finds

December 26, 2003

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994

The Lancet Oncology Retracts Potti Paper, NEJM Doesn’t

February 4, 2011

Bladder Cancer Epidemiological Study Involves 3,000 Patients

March 2, 1979

Editorial: Rumor Mill Fills The Gap When Access Denied

December 16, 1994

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014